David J. Blanchard

Array ( [id] => 5637440 [patent_doc_number] => 20060068413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => utility [patent_app_number] => 11/090729 [patent_app_country] => US [patent_app_date] => 2005-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 34139 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20060068413.pdf [firstpage_image] =>[orig_patent_app_number] => 11090729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7226522 [patent_doc_number] => 20050261480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Super humanized antibodies' [patent_app_type] => utility [patent_app_number] => 11/054669 [patent_app_country] => US [patent_app_date] => 2005-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12062 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261480.pdf [firstpage_image] =>[orig_patent_app_number] => 11054669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6951789 [patent_doc_number] => 20050226883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Humanized antibody' [patent_app_type] => utility [patent_app_number] => 11/050435 [patent_app_country] => US [patent_app_date] => 2005-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21214 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20050226883.pdf [firstpage_image] =>[orig_patent_app_number] => 11050435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5880932 [patent_doc_number] => 20060030015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Novel process for producing antibody enzyme, novel antibody enzyme and utilization thereof' [patent_app_type] => utility [patent_app_number] => 11/037199 [patent_app_country] => US [patent_app_date] => 2005-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 40301 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20060030015.pdf [firstpage_image] =>[orig_patent_app_number] => 11037199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 795729 [patent_doc_number] => 07429645 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-30 [patent_title] => 'Humanized anti-lymphotoxin beta receptor antibodies' [patent_app_type] => utility [patent_app_number] => 11/021819 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 16389 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/429/07429645.pdf [firstpage_image] =>[orig_patent_app_number] => 11021819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6951769 [patent_doc_number] => 20050226863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Single-domain antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/995074 [patent_app_country] => US [patent_app_date] => 2004-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 35202 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20050226863.pdf [firstpage_image] =>[orig_patent_app_number] => 10995074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6982829 [patent_doc_number] => 20050152899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'EphA2 agonistic monoclonal antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/994129 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 37630 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20050152899.pdf [firstpage_image] =>[orig_patent_app_number] => 10994129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 907690 [patent_doc_number] => 07332582 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-19 [patent_title] => 'Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency' [patent_app_type] => utility [patent_app_number] => 10/994091 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 33 [patent_no_of_words] => 31615 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/332/07332582.pdf [firstpage_image] =>[orig_patent_app_number] => 10994091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596261 [patent_doc_number] => 20060160178 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Methods of generating antibody diversity in vitro' [patent_app_type] => utility [patent_app_number] => 10/991309 [patent_app_country] => US [patent_app_date] => 2004-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 28184 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160178.pdf [firstpage_image] =>[orig_patent_app_number] => 10991309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6957840 [patent_doc_number] => 20050214210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Antibodies that immunospecifically bind to TRAIL receptors' [patent_app_type] => utility [patent_app_number] => 10/986376 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 137949 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214210.pdf [firstpage_image] =>[orig_patent_app_number] => 10986376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7097158 [patent_doc_number] => 20050129616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Antibodies that immunospecifically bind to TRAIL receptors' [patent_app_type] => utility [patent_app_number] => 10/986046 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 137890 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20050129616.pdf [firstpage_image] =>[orig_patent_app_number] => 10986046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7097241 [patent_doc_number] => 20050129699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Antibodies that immunospecifically bind to TRAIL receptors' [patent_app_type] => utility [patent_app_number] => 10/986047 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 137817 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20050129699.pdf [firstpage_image] =>[orig_patent_app_number] => 10986047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6957839 [patent_doc_number] => 20050214209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Antibodies that immunospecifically bind to TRAIL receptors' [patent_app_type] => utility [patent_app_number] => 10/986349 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 137844 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214209.pdf [firstpage_image] =>[orig_patent_app_number] => 10986349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5193481 [patent_doc_number] => 20070081965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Hair conditioning compositions' [patent_app_type] => utility [patent_app_number] => 10/579649 [patent_app_country] => US [patent_app_date] => 2004-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4538 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20070081965.pdf [firstpage_image] =>[orig_patent_app_number] => 10579649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7038871 [patent_doc_number] => 20050158305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Humanized antibodies to CD38' [patent_app_type] => utility [patent_app_number] => 10/965585 [patent_app_country] => US [patent_app_date] => 2004-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9120 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158305.pdf [firstpage_image] =>[orig_patent_app_number] => 10965585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7183088 [patent_doc_number] => 20050191342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity' [patent_app_type] => utility [patent_app_number] => 10/963999 [patent_app_country] => US [patent_app_date] => 2004-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 26018 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191342.pdf [firstpage_image] =>[orig_patent_app_number] => 10963999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7074338 [patent_doc_number] => 20050147606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Anti CD44 antibodies for eradicating stem cells' [patent_app_type] => utility [patent_app_number] => 10/960699 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2869 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20050147606.pdf [firstpage_image] =>[orig_patent_app_number] => 10960699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7004682 [patent_doc_number] => 20050169995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Modulation of gastrointestinal epithelium proliferation through the Wnt signaling pathway' [patent_app_type] => utility [patent_app_number] => 10/958531 [patent_app_country] => US [patent_app_date] => 2004-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10406 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20050169995.pdf [firstpage_image] =>[orig_patent_app_number] => 10958531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 507851 [patent_doc_number] => 07195764 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-27 [patent_title] => 'Cancerous disease modifying antibodies' [patent_app_type] => utility [patent_app_number] => 10/944664 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5645 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/195/07195764.pdf [firstpage_image] =>[orig_patent_app_number] => 10944664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7176084 [patent_doc_number] => 20050123534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Humanised antibodies' [patent_app_type] => utility [patent_app_number] => 10/937971 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16331 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20050123534.pdf [firstpage_image] =>[orig_patent_app_number] => 10937971 [rel_patent_id] =>[rel_patent_doc_number] =>)